Abstract:Purpose To observe the development of glaucoma in myopic eyes with and without myopic optic neuropathy (MON) and analyze associated factors to the development of typical glaucomatous damage. Design A prospective, observational, cohort study Methods A total of 233 myopic eyes with no definite evidence of glaucomatous damage were included in the study. Myopic patients without any retinal nerve fiber layer (RNFL) or visual field (VF) abnormalities were classified as myopic eyes without MON. Myopic patients with decreased RNFL at the superonasal (SN) or nasal area, and with corresponding VF defects either in the temporal or inferotemporal (IT) region, which is different from glaucomatous damage, were classified as myopic eyes with MON. Myopic eyes that developed glaucoma were defined by the presence of glaucomatous VF in the SN region including defects in Bjerrum area, or a new localized RNFL defect in the IT region on red-free photography or RNFL OCT. Disc morphological features and optic nerve head (ONH) parameters of two groups were compared. Hazard ratios for the association between baseline factors and conversion to glaucoma were obtained using Cox regression analysis. Results Mean follow-up period was 11.66 ± 2.86 years. Myopic eyes with MON had a thinner average peripapillary RNFL thickness (P < 0.001), worse MD of the VF (P = 0.031), a higher percentage of IT VF defects (P < 0.001), smaller torsion degree (P = 0.047), and greater LCD (P = 0.022). Myopic eyes with MON who developed glaucoma had a thinner average peripapillary RNFL thickness (P = 0.009), greater PPA area (P = 0.049), greater LCD (P < 0.001), and thinner LCT (P < 0.001). Thinner baseline temporal RNFL thickness (HR, 0.956; 95% CI, 0.928–0.986; P = 0.004), greater baseline LCD (HR, 1.003; 95% CI, 1.000–1.005; P = 0.022), and greater PPA area (HR, 1.000; 95% CI, 1.000–1.003; P = 0.050) were significantly associated factors with glaucoma development in the Cox regression analysis. Conclusion Myopic eyes with MON have a greater risk to develop glaucoma compared to myopic eyes without MON. Myopic eyes with MON had larger PPA area, greater LCD, and thinner temporal peripapillary RNFL, indicating that accompanying structural weakness due to myopia, especially at the temporal side of the optic nerve head and the peripapillary sclera, increases the risk of glaucoma in myopic eyes with MON.

Factors associated with the development of exudation in treatment-naive eyes with nonexudative macular neovascularization

Morphological Biomarkers Predicting Exudative Conversion in Type 1 Nonexudative Macular Neovascularization Using OCT Angiography

Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography

MICROVASCULAR CHANGES IN TREATMENT-NAÏVE NONEXUDATIVE MACULAR NEOVASCULARIZATION COMPLICATED BY EXUDATION

Natural History of Subclinical Neovascularization in Nonexudative Age-Related Macular Degeneration Using Swept-Source OCT Angiography

Reduction of retinal vessel density in non-exudative macular neovascularization: a retrospective study

Factors contributing to the development of choroidal microvasculature dropout in glaucoma suspects and patients with glaucoma

Optical Coherence Tomography Biomarkers for Conversion to Exudative Neovascular Age-related Macular Degeneration

RISK OF EXUDATION IN EYES WITH NONEXUDATIVE POLYPOIDAL CHOROIDAL VASCULOPATHY

Quantitative Evaluation of Type 1 and Type 2 Choroidal Neovascularization Components Under Treatment With Projection-Resolved OCT Angiography

Choroidal Changes After Anti-VEGF Therapy in AMD Eyes With Different Types of Macular Neovascularization Using Swept-Source OCT Angiography

Difference Between the Incidence of Retinal Fluid Subtypes and Their Association with Visual Outcomes According to the Types of Macular Neovascularization in a Korean Population

Risk Factors for Developing Neovascular Glaucoma in Central Retinal Vein Occlusion: Two-Year Real-World Study

Association between the response of intravitreal antivascular endothelial growth factor injection and systemic factors of diabetic macular edema

Analysis of the Natural Course of Quiescent Macular Neovascularization with Optical Coherence Tomography Angiography

An automated comparative analysis of the exudative biomarkers in neovascular age-related macular degeneration, The RAP Study: Report 6

The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration

Detection of macular neovascularization in eyes presenting with macular edema using optical coherence tomography angiography and a deep-learning model

Clinical Characteristics and Associated Factors to the Development of Glaucoma in Eyes with Myopic Optic Neuropathy

Macular neovascularization

Long-term Incidence and Risk Factors of Macular Fibrosis, Macular Atrophy, and Macular Hole in Eyes with Myopic Neovascularization